PPCB
Propanc Biopharma·NASDAQ
--
--(--)
--
--(--)
PPCB Filings
Filing Date
Form Description
Form Type
2026-03-31
Form DEF 14C - Other definitive information statements
2026-03-31 ·
Form DEF 14C - Other definitive information statements
2026-03-20
Form PRE 14C - Other preliminary information statements
2026-03-20 ·
Form PRE 14C - Other preliminary information statements
2026-03-19
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-03-19 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-03-06
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-06 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-26
Form 8-K - Current report
Key Events
2026-02-26 · Key Events
Form 8-K - Current report
2026-02-25
Form EFFECT - Notice of Effectiveness
2026-02-25 ·
Form EFFECT - Notice of Effectiveness
2026-02-19
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026-02-19 ·
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026-02-17
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-02-17 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026-02-02
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-02 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
